Pekin Hardy Strauss’s Medtronic MDT Stock Holding History

Pekin Hardy Strauss’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-500	Closed	-$52K	–	286
2020 Q3	$52K	Hold	500	–	–	0.01%	236
2020 Q2	$46K	Hold	500	–	–	0.01%	208
2020 Q1	$45K	Hold	500	–	–	0.01%	189
2019 Q4	$57K	Buy	+500	New	+$54.9K	0.01%	224

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Pekin Hardy Strauss's MDT Position: Q2 2026 in Review

Pekin Hardy Strauss reduced its Medtronic (MDT) stake by 0.91% in Q2 2026, selling an estimated $7.34K and leaving 9,872 shares worth $772K. The position accounts for 0.07% of the portfolio, ranked #251.

Pekin Hardy Strauss first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.52M in Q2 2023. 2,141 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Pekin Hardy Strauss held 9,872 shares of Medtronic worth $772K as of Q2 2026.
Pekin Hardy Strauss sold 91 Medtronic shares in Q2 2026, an estimated $7.34K.
Medtronic made up 0.07% of Pekin Hardy Strauss's portfolio in Q2 2026, its #251 holding.
Pekin Hardy Strauss first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
Pekin Hardy Strauss's Medtronic position peaked at $6.52M in Q2 2023.
2,141 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Pekin Hardy Strauss's 13F filing for Q2 2026, filed 30 Jul 2026.